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ABSTRACT
Retinitis pigmentosa (RP) is a term used to describe a wide variety of inherited
degenerative diseases that affect the eye. While there are many causes of this disease, the most
commonly found mutation that causes RP in North America is an autosomal dominant missense
mutation in rhodopsin (RhoP23H). Previous studies have shown that RhoP23H is predominantly
misfolded, resulting in a dramatic loss of the ability to stably bind 11-cis retinal and thus
function as a photopigment. Previous work has shown that this process is conserved to some
degree across many models, from pigs to mice, and even is evident when mutant mammalian
rhodopsin is exogenously expressed in flies. Presently, there is limited information on the
mechanism(s) that detect and degrade rhodopsin. To investigate this phenomenon, we cultured
transgenic Drosophila melanogaster and evaluated expression of exogenous rhodopsin through
western blot analysis. Our results suggest that the fly system is capable of simulating a realistic
environment for murine rhodopsin. By harnessing the powerful genetic tools surrounding the fly
system, future studies using RNAi techniques may be able to elucidate identification and
degradation pathways important to the progression of RP.
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EXECUTIVE SUMMARY
Sight is a complex sense made possible by the combination of many signaling pathways.
Central to this process is an important cycle of protein modifications that convert energy from
light to processed electrical signals in specialized cells called photoreceptors. The light-sensitive
protein receptor responsible for this process of phototransduction in rod photoreceptors is called
rhodopsin. Protein modification of rhodopsin has been observed to be a largely conserved feature
of visual systems across the animal kingdom.
The complexity of the visual cycle leaves a lot of room for error. Small mutations in
functional portions of DNA have been observed to have major consequences for the cycle as a
whole. For example, a single missense mutation, resulting in an amino acid change from proline
to histidine in the sequence that encodes the protein rhodopsin, is known to cause a disease
named Retinitis pigmentosa (RP). On the biochemical level, this single missense mutation causes
a misfolding of the proteins 3D structure. This aberrant conformational change in rhodopsin
increases the propensity of aggregate formation in the retina. The accumulation of these
aggregates has been shown to cause degeneration of first, rod photoreceptors, and then cone
photoreceptors, which results in the patient level symptoms of progressive vision loss that leads
to eventual blindness.
Mutations of this nature are not unique to the human system. This phenomenon has been
observed in other models, including: large mammals9, invertebrates8, and even cultured cells10.
While the outcome is known, the mechanism is largely unresolved.
Previous studies in mice have shown that observed RhoP23H expression is much lower
than wild-type controls14. This suggests that mutant rhodopsin is recognized in the cell before it
is transported to its functional location in the outer segment of the photoreceptor. Other
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experiments using transgenic frogs17, and mice18 have shown disruptions in the membrane
integrity of the specialized outer segment of the rod cell where phototransduction occurs.
Therefore, it seems reasonable to propose that the RhoP23H that escapes degradation and is
transported to the outer segment is contributing to rod death. By identifying and exploiting the
pathways which recognize and degrade mutant rhodopsin through drug or gene therapy, it may
be possible to halt or even prevent this diseases progressive fate.
The core aim of my project was to develop a protocol for screening genes of interest
related to the identification and degradation of RhoP23H. In our model, mRhoP23H was
exogenously expressed through the utilization of a Gal4-UAS system with an Rh1 promoter.
Meaning that a mutant mouse gene for rhodopsin was inserted and expressed at a target location
in the fly’s eye. By characterizing the behavior of mRhoP23H and mRhowt using western blot
techniques, a baseline was set for future investigations using RNAi techniques. The baseline was
expected to show a constant expression of mRhowt across several ages and a decrease across ages
for mRhoP23H. The purpose of this baseline test was to confirm transgene expression and
establish the correct size of gene products. However, results suggested that our controls were not
behaving as previously understood. Both the mRhowt and mRhoP23H fly lines displayed odd
trends of degradation across different aged flies.
To further investigate this phenomenon, the fly lines were cleared of balancer
chromosomes by selection and/or mating techniques. Flies were collected upon eclosion, which
is when they come out of their pupal case, and reared to different ages upon which their heads
were collected for protein analysis. The fly ages for the sample collections include days: 5, 7, 9,
11, and 14. Collected heads were separated by age, gender, and genotype before being
homogenized and prepared for western blot analysis.
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Results showed that the mRhowt follows a similar pattern of expression to that of a
congruent system, which instead of using exogenously expressed mRho (from mice) used bRho
(from cattle)38. Our results also confirmed that exogenously expressed mRhoP23H is severely
degraded, suggesting that the mechanism for identification and degradation of misfolded protein
is conserved across mice and flies. This fortifies the usage of flies as a model system for studying
this phenomenon. Flies offer many advantages in genetic studies which can be more easily
exploited as compared to the mouse system. Through the use of readily available transgenic
lines, identification and degradation pathways can be investigated through the use of the fly
system with mouse rhodopsin.
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ADVICE TO FUTURE HONORS STUDENTS
If I had to offer two pieces of advice to future honors students, I would say this:
Start your capstone early, and make sure it is on something you enjoy because you will undoubtedly be
spending an enormous amount of time on it.
And while we are speaking of time, you have much less than you may think.
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INTRODUCTION
Retinitis pigmentosa (RP) is the umbrella term for a large set of inherited degenerative
eye diseases that affect the retina. The retina is the light-sensitive tissue in the back of the inner
eye that is responsible for converting what we see into electrical signals that then get sent to the
brain via the optic nerve1. RP is the causal factor of more than 1 million cases of blindness
worldwide. While the disease is well characterized and easily diagnosed, there remains no
effective cure. RP dramatically degrades this process by causing the photoreceptor cells to die.
Most often, the rods, which are responsible for dim light vision, are first (primary) affected and
secondarily cones, which are responsible for daytime and color vision, are lost. The loss of these
cells, which line the outermost layer of retina, results in the characteristic symptoms of RP.
Initially, the disease presents itself as nyctalopia or night blindness, a condition in which it is
difficult for the patient to see clearly in dim light conditions. Because the rods are distributed in
the periphery of the retina in humans while cones are concentrated in the macular (central
region), the earliest symptoms are in peripheral vision while maintaining clear vision in their
central field (Figure 1). As the condition worsens, rod cells continue to die and central regions of
the retina start to degenerate, patients begin to experience loss of their central vision2. Other
forms of RP exist, for example cone-rod dystrophy (CRD), in which the primary cell death
includes both cones and rods, thus affecting central vision more severely earlier than other forms.

FIGURE 1. SIMULATION OF RETINITIS PIGMENTOSA (IMAGE 1)
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RP is linked to many different genetic loci with about half the cases inherited3, through
one of three genetic inheritance patterns: autosomal recessive, autosomal dominant or X-linked.
The most commonly found mutation that causes RP in North America is an autosomal dominant
missense mutation in rhodopsin (RhoP23H). Rhodopsin is the photosensitive pigment that is
expressed in rod cells and absorbs light to initiate vision4. The mechanism by which the mutant
rhodopsin causes rods to die is unknown, and the development of therapeutic strategies is
therefore limited. A number of research groups have developed gene therapy approaches that
have the potential to slow or reduce retinal degeneration5. However, these approaches are still in
the early phases and the associated costs are not clear. A better understanding of the fate of
RhoP23H protein could identify cellular pathways that could be targeted for drug development.
This project aims to uncover such pathways using a powerful model system.
Previous studies have shown that RhoP23H is predominantly misfolded, resulting in a
dramatic loss of the ability to stably bind 11-cis retinal and thus function as a photopigment 6,7.
Very little is known about the fate of RhoP23H in human retina, so model organisms have been
used extensively, from invertebrates8 to large mammals9, in addition to cultured cells10. The
recent development of a knock-in mouse model11 has provided a disease model without the
complications of transgenic lines that overexpress rhodopsin12,13. In the knock-in heterozygote
mouse, the RhoP23H protein levels are much lower compared to the wild-type protein14,
suggesting most but not all of the mutant protein is targeted for degradation. However,
haploinsufficiency does not explain the effects of RhoP23H on rod survival, since in hemizygous
rhodopsin (Rho/-) knock-out mice, the photoreceptors degenerate with a much slower time
course than Rho/RhoP23H 15,16. Thus, it appears that there is a “dominant-negative” effect of the
RhoP23H protein, even at the low expression observed in the knock-in mice. Experiments using
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transgenic Xenopus17, and knock-in mice18 have shown disruptions in the membrane integrity in
the specialized outer segment compartment where phototransduction occurs. Therefore, it seems
reasonable to propose that the RhoP23H that escapes degradation and is transported to the outer
segment is contributing to rod demise.
At present, there is limited information of the mechanism(s) that detect and degrade
mutant rhodopsin. Although there have been extensive experiments using cultured mammalian
cells19,20, the applicability of the cell line responses to that in photoreceptor is questionable21,22.
So, it is important that mechanistic studies be designed to investigate photoreceptors.
In most cells, there are primarily two methods of protein degradation, lysosome-mediated
and proteasome-mediated. Each method of degradation has several pathways to eventual protein
degradation and could be the underlying cause of photoreceptor death in Rho P23H. The goal of
my capstone project will be to determine if either pathway is involved in RhoP23H degradation so
that future studies can work towards an understanding of its process. Currently, it is thought that
through an endoplasmic-reticulum-associated-degradation (a lysosome-mediated process),
misfolded RhoP23H proteins are recognized by an unknown protein and degraded. The proposed
cause of photoreceptor death is the accumulation of residual or partially digested protein that
becomes toxic for affected cells. Under this assumption, by identifying this protein we will be
able to investigate in detail the mechanism of RhoP23H identification and degradation. Future
goals of this research will be to develop methods to aid in the degradation of misfolded
rhodopsin, thus reducing cellular toxicity, which in return may save the photoreceptor cells.
Previous approaches to large-scale screenings have been expensive, time consuming and
often problematic. Using mammalian cells, and other animal models for exploratory studies have
proven to be highly inefficient and time consuming. Using cell culture, an approach usually well
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suited for studies such as this one, have proven to be problematic when Rho is involved because
of its toxicity in cell lines when high concentration of exogenous Rho is present24. To screen for
possible pathways affecting rhodopsin degradation, I will use a novel approach with Drosophila
(fruit flies).
Many aspects of the Drosophila model are favorable for such an approach: fly
photoreceptors produce rhodopsin in large amounts and elaborate light-sensitive membranes
specialized for phototransduction25, and Drosophila are a well-characterized model used
extensively in genetic research, especially for gene discovery. Drosophila’s minimal
maintenance and low cost, make them efficient and cost effective for larger scale studies. Since
Drosophila are so well studied, there are many tools for genetic analysis at the cellular and
molecular level. But most importantly, Drosophila, like mammals, possess photoreceptor
neurons with the unique ability to synthesize large amounts of protein-rich membranes. New
studies by the Pignoni and Knox labs have shown that Drosophila photoreceptors can express
mouse Rho and transport the wild type protein to the appropriate membranes26. Moreover, in
unpublished studies31, mutant RhoP23H was degraded in photoreceptors over approximately two
weeks while the wild type Rho was stably expressed. This restates a key feature of the mouse
knock-in model, selective degradation of RhoP23H, and supports the use of Drosophila for
dissecting the degradation pathway.
While there are many similarities between Drosophila and vertebrate models, it is
important to note that there are many distinct differences as well. Drosophila’s photosensitive
photoreceptors are elaborated microvilli structures of stacked membranes called
rhabdomeres27,30, while rods are modified cilia with stacks of membrane disks28. Dropsophila
and vertebrate phototransduction pathways follow similar conserved mechanisms of initial
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events in transduction but diverge in terms of specific intermediates and interpretations of
absorbed photons27.36.
Under the direction of the Knox Laboratory and in collaboration with the Pignoni
Laboratory at Upstate Medical University, a lab with specialty in Drosophila research, I will
have the necessary mentorship and tools to effectively investigate my research goal. Using the
fly model and RNA interference methods, I will search for RNAi lines that alter the degradation
rate of RhoP23H. The basic approach will be to select various lines from the Drosophila stock
centers and to cross those flies with the existing Drosophila lines in the Pignoni lab that express
either mRhowt-eGFP or mRhoP23H-eGFP genes30. I will grow the flies for one to two weeks and
then determine Rho protein levels using quantitative western blotting based upon luminescence
detection32. In this way, I hope to identify candidates that may be involved in recognizing
misfolded protein or directing misfolded protein to the degradation enzymes. Rhowt-eGFP will
serve as a control for the specificity of the RNAi line to degradation. The Specific aims of my
research project are to:
1. To create Drosophila lines expressing RNAi for enzymes potentially involved in
recognizing misfolded proteins, these will include initially E3 ubiquitin ligases and
related genes, chaperonins, N-linked glycosylation pathway enzymes and endoplasmic
reticulum-specific lectins33,34,35, the precise number of lines will depend upon how readily
the crosses can be prepared and how variable the expression level of the Rho transgene is
in the various RNAi lines;
2. To confirm quantitative western blot analysis of Rhowt-eGFP and RhoP23H-eGFP in one to
two-week old Drosophila is suitable for my screen. I will optimize the western blot as
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needed. As controls, the VCP/ter948 and dPob/EMC36 lines will be tested, as those genes
have been implicated in the biosynthetic pathway for endogeneous Drosophila rhodopsin.
For every RNAi that induces altered degradation of RhoP23H-eGFP compared to Rhowt-eGFP,
I will:
1. Confirm that degradation occurs at the RhoP23H-eGFP protein level and not the mRNA
level by showing transcript stability by qRT-PCR;
2. Confirm that the mRNA level for the targeted degradation gene has indeed decreased,
using qRT-PCR and/or immunostaining if the antibodies are available commercially.

These experiments should permit an initial screen for potential genes of interest in the
degradation of mutant rhodopsin.
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MATERIALS AND METHODS
A. FLY CROSSES
Initial fly stocks were previously created by the Pignoni Lab (SUNY Upstate Medical
University, NY). They were created by transforming white plus marked flies with mRho
constructs in a white minus background.
Balancers were eliminated by a brother and sister intercross, followed by a cross to a
wild-type white eye fly line (w1118; cs). Fly line “NT” received no modifications. For each –eGFP
fly line, an -mCherry variation was made as well for future studies. A homozygous mRhoP23HmCherry was not sufficiently viable to establish a pure stock. Balancers were eliminated from fly
line “D” by crossing it to w1118, followed by selection of phenotypic characteristics. The resulting
genotypes of produced fly lines are listed below in Table 1.
Table 1. Genotypes of modified fly lines.
Fly Line Abbreviation
A
B
NT
D
F

Genotype 1
Rh1-Gal4 , UAS-mRhowt-eGFP
- // Rh1-Gal4 , UAS-mRhoP23H-eGFP
- // w;
SM5
T(2,3)apxa
Rh1-Gal4 , UAS-mRhowt-eGFP
- // Rh1-Gal4 , UAS-mRhowt-eGFP
- // -

B. FLY REARING
Flies were reared and maintained at 25°C, unregulated humidity, in a 12-hour light/dark
cycle. Adult flies, collected upon eclosion, were maintained with lab-made agar-based diets
consisting of cornmeal, dextrose, agar, water, propionic acid, 20% tegosept and yeast (adapted

1

“- // -“ denotes the fly line is a heterozygote, “m” denotes murine
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from a Perkin’s lab recipe). Flies were collected twice each day, once in the morning and once at
night. Each collection was reared independently until desired age was reached.

C. FLY HEAD HARVESTING
Heads were collected from female flies on days 5, 7, 9, 11, and 14 days after eclosion.
Head collection was performed on a sanitized CO2 flypad post CO2 anesthesia with a sanitized
scalpel. Collected heads were separated by gender, genotype, and age and immediately frozen in
1.7mL microcentrifuge tubes on dry ice after they were obtained. Collected fly heads were stored
at -80°C until processed.

D. WESTERN BLOT ANALYSIS
For each sample, 20 frozen female fly heads were homogenized in 60uL of opsin
solubilization buffer (OSB) (1X PBS, pH 7.4, 1mM EDTA, pH 8.0, 1% DM (n-dodecyl-beta-Dmalto (pyrano) side), and 1 tablet of Roche cOmplete™ Mini Protease Inhibitor, EDTA Free))
via tube and pestle over ice. Sample protein concentrations were calculated via Bio-RAD DC™
Protein Assay and normalized with excess OSB. See Figure 1 for protein extraction efficiency.
Lysates were diluted in 4x Laemmli sample buffer (277.8 mM Tris-HCl, pH 6.8, 44.4% glycerol,
4.4% LDS, 0.02% bromophenol blue, and 10% 2-mercaptoethanol) prior to storage at -20°C.
80ug of denatured protein was loaded into precast 10% SDS- polyacrylamide gels (Bio-Rad
Mini-PROTEAN® TGX™), with a ladder mixture (3uL Thermo Scientific™ PageRuler™ Plus
Prestainied Protein Ladder, and 10uL Thermo Scientific™ MagicMark™ XP Western Protein
Standard) and separated by electrophoresis at 0.03 amperes for about 50 minutes. Separated
samples were transferred to a polyvinylidene difluoride membrane (Immun-Blot® PVDF),
blocked in blocking buffer (BB) (5% powdered milk, 0.1% Tween 20 in PBS) and incubated for
at least 16 hours overnight at 4°C with a primary antibody, mouse monoclonal 1D4 (University
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of British Columbia), 1: 5,000 dilution in BB. Overnight blots were then incubated with a
secondary antibody, goat anti-mouse HRP (Sigma), 1: 10,000 dilution in BB, at room
temperature for one hour. Membranes were visualized by Enhanced Chemiluminescence (ECL)
detection with Bio-Rad Clarity™ Western ECL Blotting Substrate or Thermo Scientific™
SuperSignal™ West Femto Maximum Sensitivity Substrate. The analysis of processed blots was
done on a Bio-Rad Molecular Imager ChemiDoc XRS+ using Bio-Rad Image Lab™ Software.

RESULTS
A. H OMOGENIZATION E FFICIENCY
Under the current sample preparation protocol, lysate total protein per sample did not vary
significantly (Figure 2). When separated by group, post-homogenization lysates of 20 female fly
heads displayed consistent levels of protein extraction (Figure 2A). When separated by age,
lysates displayed uniform dispersion in all age categories with minor variation (Figure 2B),
signifying no correlation between age and extraction efficiency. We believe that minor
differences are not real differences in protein per head, but rather reflect improvements in the
operator’s technique.

B. WESTERN BLOT ANALYSIS
Figure 3 depicts detection of bands using primary antibody mouse monoclonal 1D4, and
secondary antibody, goat anti-mouse IgG-Peroxidase, with ECL reagents. Figure 3A shows the
state of our eGFP wild-type control (mRhowt-eGFP) prior to the elimination of the balancer
chromosome. Results from this line show that the expression of the transgene was variable,
displaying a period of rapid increase in expression from Day 5 to Day 7, followed by a severe
drop off between days 7 and 9. Figure 3B displays mRhowt-eGFP following the removal of the
balancer chromosome from the stock. The detection of mRhowt-eGFP was predominately at ~55
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kda. These bands display slight smearing which may indicate some level of variable protein
glycosylation in the individual rhodopsin molecules. Through volumetric and visual analysis, it
is evident that protein detection is decreasing overtime. Between Day 5 and Day 9, detection
decreases 17%, followed by a decrease of ~30% from Day 9 to Day 14 (Figure 3C).
To evaluate bands of interest from non-specific bands, we conducted a western blot with a
negative control. In Figure 3D, non-Rho transgenic SM5/T(2,3)apxa, labelled “NT” was
compared to mRhoP23H-eGFP, labelled B5, both at 5 days of age. The mRhoP23H-eGFP lane
displays one band that is very faint around 115 kda, labelled with a red arrow, which is not
present in the non-Rho transgenic lane. We deduce that this may represent the dimer of
mRhoP23H-eGFP. We were also expecting to see a faint band around 55 kda in lane B5,
signifying the existence of the monomer, but it appears that because of low expression or transfer
efficiency this band is not visible. However, comparing lane NT to blot “E” reinforces our
assumption that the band seen at ~55 kda in blot “E” is in fact our protein of interest.
The transgenic mRhoP23H-eGFP flies were observed to be much dimer under epiflourescence
microscopy as compared to the mRhowt-eGFP line. In western blot analysis, this low expression
was also observed. In Figure 3E, the detection of the monomer for mRhoP23H-eGFP was
observed at ~55 kda, with variety of other bands. The increase in band detection can be, in part,
connected to the use of the ECL reagent Femto which is a much more sensitive substrate than
Clarity which was used for Figure 3B. It is important to note, however, that even with Femto,
exogenous rhodopsin detection was extremely low. Other notable bands: ~110 kda may represent
the dimer of mRhoP23H-eGFP. Volumetric analysis of the monomer bands show a trend of
logarithmic increase from Day 5 until Day 9, followed by negative linear regression from Day 9
to 14 resulting in a loss of expression of ~56% over five days (Figure 3F).
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Figure 2. Post-homogenization total protein of 20 female fly heads. A. Processed samples separated into groups
by fly lines. Each dot represents 20 female fly heads collected as a group on different days. B. Processed samples
separated into groups by age of heads. Each dot represents 20 female fly heads collected as a group on different
days.
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Figure 3. Western blot analysis of Rho variants of flies at different ages. A. Western blot analysis of fly line A (mRho w t -eGFP,
mixed stock with TM3 variance) for days 5, 7, and 9. 80 ug of homogenate per lane, immunodetection with mouse monoclonal 1D4,
chemiluminescent with goat anti-mouse IgG-Peroxidase with Thermo Scientific™ SuperSignal™ West Femto Maximum Sensitivity
Substrate, 7 second exposure. B. Fly line A (mRho w t -eGFP with balancer chromosome TM3 eliminated) analysis of days 5, 7, 9, 11, and
14. 80 ug of homogenate per lane, immunodetection with mouse monoclonal 1D4, chemiluminescent with goat anti-mouse IgGPeroxidase with Bio-Rad Clarity™ western ECL substrate, 112.7 second exposure. C. Volumetric analysis using intensity of blot “B”
with Bio-Rad Image Lab™ Software. D. Negative Control with: NT- non-Rho transgenic SM5/T(2,3)ap x a and B5- mRho P 2 3 H -eGFP at 5
days of age. 80 ug of homogenate per lane, immunodetection with mouse monoclonal 1D4, chemiluminescent detection with goat antimouse IgG-Peroxidase with Thermo Scientific™ SuperSignal™ West Femto Maximum Sensitivity Substrate, 105.8 second exposure.
Red arro w indicates band not present in NT. E. Fly line B (mRho P 2 3 H -eGFP) analysis of days 5, 7, 9, 11, and 14. 80 ug of homogenate
per lane, immunodetection with mouse monoclonal 1D4, chemiluminescent detection with goat anti-mouse IgG-Peroxidase with Thermo
Scientific™ SuperSignal™ West Femto Maximum Sensitivity Substrate, 49.4 second exposure. F. Volumetric analysis of the monomer
bands using intensity of blot “D” with Bio-Rad Image Lab™ Software.
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DISCUSSION
An Rh1-mediated Gal4-UAS system was chosen, as opposed to other more general
expression drivers (namely glass multiple reporter (GMR)), in an attempt to simulate the most
authentic environment for our protein of interest. While it is has been shown that GMR produces
much higher desired protein expression levels as compared to Rh137, it is difficult to evaluate cell
specific protein fates, such as that of rhodopsin, when expression levels are evaluated from nonspecific techniques. The use of an Rh1 promoter restricts transgene expression to cells that
already express rhodopsin.
At first, our wild-type positive control did not represent expectations (Figure 3A).
Following intervention, which included removing balancer chromosomes, our wild-type
displayed a very different, more expected, expression pattern (Figure 3B). There may be various
reasons for the differences between Figures 3A and 3B, however without further analysis it is
difficult to speculate the definitive cause. Several contributing factors may be, but are not limited
to: extreme variance in the genotypes of flies within a single sample, a mutation on the balancer
chromosome, or a high concentration of homozygous carriers of the transgene which could result
in either extreme expression or degraded expression as a result of cellular toxicity from high
concentrations of rhodopsin.
The ages of flies used for our assays was determined from the results of a previous study
that used flies with exogenously expressed bovine rhodopsin38. This study showed that in wildtype Rh1-mediated Gal4-UAS systems, exogenous bovine rhodopsin expression reached a socalled “steady state” by Day 3 which was maintained until at least Day 10. Establishing a “steady
state” provides a predictable positive control to compare the results of future genetic
manipulations effects on the fate of mRho. While we were unable to obtain a perfect “steady
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state” of expression, our results do follow a congruent trend to Ahmad S. et al 2006. These
results suggest several possibilities for the current state of our transgenic wild-type fly line
(Figure 3B). A probable explanation is that murine rhodopsin may be inherently less stable than
bovine rhodopsin when utilized this way, or there is still another factor contributing to the slow
degradation of mRhowt. A factor that may contribute to this instability is the enhanced green
fluorescent protein (eGFP) tag attached to our transgene which was not used in Ahmad S. et al
2006. While there are powerful implications to keeping this tag, namely quick screening through
epiflourescent microscopy, eGFP’s large size or biochemical characteristics may be contributing
to the transgenes instability over time. A follow up experiment, which due to time constraints we
were unable to perform, involved the use of a second set of transgenes with mCherry fluorescent
tags (fly lines “D” and “F”). mCherry has been shown to have a fast maturation, good pH
resistance, tolerance to N-terminal fusions39, and a low propensity for dimerization due to its
monomer form.
Figure 3E confirms existing understanding that the RhoP23H mutation results in extreme
degradation of protein expression. This phenomenon requires highly potent ECL reagents to
detect small fluctuations in band intensity leading to the subsequent detection of many nonspecific bands. The trend of an exponential increase in expression followed by steady decline
offers a few interpretations (Figure 3F). It is possible that the cells are quickly overwhelmed by
an exponentially increasing amount of un-degraded or partially degraded misfolded protein. This
may result in a toxic or unfavorable environment for the rod photoreceptors leading to the
degradation of the cells. To assess this theory, this experiment would need to be redone with
additional steps to evaluate endogenous rhodopsin expression.
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For future investigations, a wider time scale, starting at Day 1 may be more appropriate.
By Day 5, it appears, because of how low the detection is even with an extremely potent ECL
reagent, mRhoP23H-eGFP may be nearing complete degradation (Figure 3E). It may be possible
that peak mRhoP23H expression occurs between Day 1 and 5. Expanding the ages analyzed for
future studies would also be beneficial for our Rhowt line. Day 5 was observed to have the
highest expression, making it difficult to infer when degradation of the protein actually began
(Figure 3B).
Nonetheless, the fact that expression of mouse rhodopsin in fly photoreceptors mimics
behavior seen in native mouse photoreceptors is both exciting and promising for future
investigations of degradation pathways using the fly system. This suggests that the signaling
pathways for detecting the misfolding and subsequent degradation of the mutant protein could be
conserved in evolution between fly and mouse. Use of the powerful genetic tools available to the
fly system, including readily available stocks with disabled genetic pathways, may prove to be a
very effective method for screening candidate genes in future investigations.

24

References
1.
2.
3.
4.
5.
6.
7.

8.
9.

10.
11.

12.
13.

14.
15.

16.
17.
18.
19.

20.
21.

22.
23.
24.
25.
26.

Yanoff M, Cameron D. Disorders of the visual system. In: Goldman L, Schafer AI, eds. Cecil Medicine
Hartong DT, Berson EL, Dryja TP. “Retinitis pigmentosa” Lancet. 2006 Nov 18;368(9549):1795-809.
Retnet: Retinal Information Network, https://sph.uth.edu/retnet/, accessed 30 September 2015.
Palczewski K. Chemistry and biology of vision. J Biol Chem. 2012, 287:1612-1619.
Lewin AS, Rossmiller B, Mao H, Gene augmentation for adRP mutations in RHO. Cold Spring Harb
Perspect Med. 2014, 4:a017400.
Miller LM, Gragg M, Kim TG, Park PS, Misfolded opsin mutants display elevated β-sheet structure. FEBS
Lett. 2015: S0014-5793(15)00812-1;
Chen Y, Jastrzebska B, Cao P, Zhang J, Wang B, Sun W, Yuan Y, Feng Z, Palczewski K. Inherent
instability of the retinitis pigmentosa P23H mutant opsin. J Biol Chem. 2014, 289:9288-303 and references
cited therein.
Griciuc A, Aron L, Roux MJ, Klein R, Giangrande A, Ueffing M. Inactivation of VCP/ter94 suppresses
retinal pathology caused by misfolded rhodopsin in Drosophila. PLoS Genet. 2010; 6 pii: e1001075.
Fernandez de Castro JP, Scott PA, Fransen JW, Demas J, DeMarco PJ, Kaplan HJ, McCall MA. Cone
photoreceptors develop normally in the absence of functional rod photoreceptors in a transgenic swine
model of retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2014; 55(4):2460-8.
Kaushal S, Khorana HG. Biochemistry, 1994; 33:6121-8, Structure and function in rhodopsin. 7. Point
mutations associated with autosomal dominant retinitis pigmentosa.
Sakami S, Maeda T, Bereta G, Okano K, Golczak M, Sumaroka A, Roman AJ, Cideciyan AV, Jacobson
SG, Palczewski K. Probing mechanisms of photoreceptor degeneration in a new mouse model of the
common form of autosomal dominant retinitis pigmentosa due to P23H opsin mutations. J Biol Chem.
2011; 286:10551-67.
Frederick JM, Krasnoperova NV, Hoffmann K, Church-Kopish J, Rüther K, Howes K,Lem J, Baehr W.
Mutant rhodopsin transgene expression on a null background.Invest Ophthalmol Vis Sci. 2001; 42:826-33.
Naash MI, Hollyfield JG, al-Ubaidi MR, Baehr W. Simulation of human autosomal dominant retinitis
pigmentosa in transgenic mice expressing a mutated murine opsin gene. Proc Natl Acad Sci U S A. 1993;
90:5499-503.
Sakami et al., 2011; Reks and Knox, unpublished data.
Lem J, Krasnoperova NV, Calvert PD, Kosaras B, Cameron DA, Nicolò M, Makino CL, Sidman RL.
Morphological, physiological, and biochemical changes in rhodopsin knockout mice. Proc Natl Acad Sci U
S A. 1999; 96:736-41.
Rakshit T, Park PS. Impact of reduced rhodopsin expression on the structure of rod outer segment disc
membranes. Biochemistry. 2015; 54:2885-94.
Haeri M, Knox BE Rhodopsin mutant P23H destabilizes rod photoreceptor disk membranes. PLoS One.
2012;7:e30101.
Sakami et al., 2011; Sakami S, Kolesnikov AV, Kefalov VJ, Palczewski K. P23H opsin knock-in mice
reveal a novel step in retinal rod disc morphogenesis. Hum Mol Genet. 2014 ;23:1723-4.
Athanasiou D, Bevilacqua D, Aguila M, McCulley C, Kanuga N, Iwawaki T, Paul Chapple J, Cheetham
ME. The co-chaperone and reductase ERdj5 facilitates rod opsin biogenesis and quality control and
references cited therein. Hum Mol Genet. 2014 Dec 15;23(24):6594-606.
Reks and Knox, unpublished results using HEK293 cell lines.
Chiang WC, Kroeger H, Sakami S, Messah C, Yasumura D, Matthes MT, Coppinger JA, Palczewski K,
LaVail MM, Lin JH. Robust Endoplasmic Reticulum-Associated Degradation of Rhodopsin Precedes
Retinal Degeneration. Mol Neurobiol. 2015; 52:679-95.
Adekeye, A. 2015, Retinitis Pigmentosa: Investigating the Role of the Unfolded Protein Response in
Photoreceptor Death, Ph.D. dissertation, SUNY Upstate Medical University, Syracuse, NY.
Minikel, Eric. Basics of protein degradation. http://www.cureffi.org/2013/07/11/basics-of-proteindegradation/. Accessed 30 September 2015.
Reks and Knox, unpublished, Adekeye, 2015.
Rister J, Desplan C. The retinal mosaics of opsin expression in invertebrates and vertebrates. Dev
Neurobiol. 2011 Dec;71(12):1212-26.
Aerni-Flessner L, Haeri M, Knox BE, Pignoni F. Can fly photoreceptors lead to treatments for rho
((P23H)) -linked retinitis pigmentosa? J Ophthalmic Vis Res. 2013; 8:86-91.

25
27. Xiong B, Bellen HJ. Rhodopsin homeostasis and retinal degeneration: lessons from the fly. Trends in
Neurosciences, November 2013, Vol. 36, No. 11.
28. Daemen FJ. Vertebrate rod outer segment membranes. Biochim Biophys Acta. 1973; 300:255-88.
29. Fain GL, Hardie R, and Laughlin LB. Phototrnsduction and the Evolution of Photoreceptors. Current
Biology 20, R114–R124, Feb. 9, 2010.
30. Pak WL. Drosophila in vision research. The Friedenwald Lecture. Invest Ophthalmol Vis Sci. 1995;
36:2340-57.
31. Reks, Aerni-Flessner, Haeri, Pignoni and Knox, in preparation
32. Peet JA, Bragin A, Calvert PD, Nikonov SS, Mani S, Zhao X, Besharse JC, Pierce EA, Knox BE, Pugh EN
Jr. Quantification of the cytoplasmic spaces of living cells with EGFP reveals arrestin-EGFP to be in
disequilibrium in dark adapted rod photoreceptors. J Cell Sci. 2004; 117:3049-59.
33. Nakatsukasa K, Kamura T, Brodsky JL. Recent technical developments in the study of ER-associated
degradation. Curr Opin Cell Biol. 2014; 29: 82-91.
34. Shiber A, Ravid T. Chaperoning proteins for destruction: diverse roles of Hsp70 chaperones and their cochaperones in targeting misfolded proteins to the proteasome. Biomolecules. 2014; 4:704-24.
35. Lemus L, Goder V. Regulation of Endoplasmic Reticulum-Associated Protein Degradation (ERAD) by
Ubiquitin. Cells. 2014; 3:824-47.
36. Satoh T, Ohba A, Liu Z, Inagaki T, Satoh AK. Elife. EMC is essential for biosynthesis of rhodopsin and
other multi-pass membrane proteins in Drosophila photoreceptors. 2015; 4.
37. Aerni-Flessner, unpublished results, 2013.
38. Ahmad S, Natochin M, Barren B, Artemyev NO, O’Tousa JE; Heterologous Expression of Bovine
Rhodopsin in Drosophila Photoreceptor Cells. Invest. Ophthalmol. Vis. Sci. 2006;47(9):3722-3728.
39. Wei W S. Fluorescent proteins as tools to aid protein production. Microbial Cell Factories. 2005. 4:12.
Images
1. Retinitis Pigmentosa. Digital image. Prakash Nethralaya. Web. 30 Sept. 2015.

